By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Scottish firm Sistemic today announced a master service agreement to use its SistemRNA suite of drug development tools to accelerate Redx Pharma's preclinical development pipeline of more than 250 new drug candidates.

The agreement follows a project between the two companies in which Sistemic "added significant value" to a lead program of Redx while saving significant costs, Sistemic said.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.